Proteotype Diagnostics Selected for EU-Funded HER-CARE Doctoral Network, Signalling Growing Research Leadership in Precision Oncology
CAMBRIDGE, England, April 27, 2026 /PRNewswire/ — Proteotype Diagnostics Ltd announced its selection as an industrial beneficiary in the HER-CARE…
